Business Context and Reporting Period
Company: SANUWAVE Health, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: June 4, 2019
Reporting Period: Event date June 4, 2019; Signed June 17, 2019.
The Company, a Nevada corporation, reported the termination of a material definitive agreement involving a joint venture.
Key Financial Metrics
This filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only specific financial figures disclosed relate to the settlement of the terminated agreement:
- Receivable for Equipment: $63,275 (outstanding amount for equipment delivered to Johnfk Medical Inc.).
- Penalty Fee: $50,000 (for early termination of the Joint Venture Agreement).
- Total Settlement Amount: $113,275.
Material Changes
On June 4, 2019, SANUWAVE Health, Inc. entered into a "Deed of Termination of Joint Venture Agreement" with Johnfk Medical Inc. ("FKS") and Holistic Wellness Alliance Pte. Ltd. ("HWA").
- Termination: The Joint Venture Agreement dated September 21, 2018, which established HWA as a joint venture between the Company and FKS, was terminated effective June 4, 2019.
- Liquidation: The Company and FKS intend to liquidate HWA as soon as reasonably practicable.
Guidance, Outlook, and Risks
Management Commentary: The filing focuses solely on the execution of the termination deed and the associated financial settlement. No forward-looking guidance or strategic outlook is provided in this document.
Risks and Contingencies: The primary contingency noted is the liquidation of the joint venture entity (HWA). The financial recovery of the $113,275 settlement amount is contingent upon FKS fulfilling its payment obligations under the Deed.
Investor Verification Checklist
- Verify the receipt of the $113,275 settlement payment ($63,275 equipment + $50,000 penalty) from Johnfk Medical Inc.
- Confirm the status and timeline of the liquidation of Holistic Wellness Alliance Pte. Ltd. (HWA).
- Review the full text of the Deed of Termination of Joint Venture Agreement (Exhibit 10.1) for additional terms or conditions not summarized in the 8-K.
- Assess the impact of this termination on the Company's future revenue streams previously associated with the joint venture.